{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"9","upperLimit":"34","value":"13"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"25"}],"units":"Participants"}],"description":"Platelet recovery is defined as \\>50,000 mm3 platelet cell count after transfusion.","dispersionType":"Full Range","groups":[{"description":"Recipients will receive induction chemotherapy with fludarabine, cyclophosphamide, etoposide, doxorubicin, vincristine, and prednisone. (one cycle is 5 days on drug therapy followed by a 16 day rest period). Prior to the transplant procedure, recipients will receive conditioning therapy followed by the infusion of donor stem cells.\n\nMethotrexate: Recipients will receive 4 doses of methotrexate by vein after the transplant to help prevent graft-versus-host disease (GVHD).\n\nCyclosporine: Recipients will receive cyclosporine by vein or by mouth for about 6 months after the transplant to help prevent graft-versus-host disease (GVHD).","id":"OG000","title":"Recipient"}],"paramType":"MEDIAN","populationDescription":"Six recipients were not evaluable for platelet recovery \\> 20K because their platelet count never fell below that level (n=2) or because they were receiving aggressive platelet transfusions (n=4).","reportingStatus":"POSTED","timeFrame":"Up to 2 months after stem cell transplant","title":"Median Time to Platelet Recovery","type":"SECONDARY","unitOfMeasure":"Days"}